نتایج جستجو برای: clozapine

تعداد نتایج: 3536  

Journal: :Schizophrenia research 2015
Tyler S Kaster Danilo de Jesus Natasha Radhu Faranak Farzan Daniel M Blumberger Tarek K Rajji Paul B Fitzgerald Zafiris J Daskalakis

BACKGROUND Cortical inhibition (CI) deficits have been demonstrated in schizophrenia using transcranial magnetic stimulation (TMS). These CI deficits may be related to decreased GABA activity which may be involved in schizophrenia pathophysiology. Previous cross-sectional studies have also demonstrated greater CI in patients treated with clozapine than other typical/atypical antipsychotics. How...

2015
Richard D. Hayes Johnny Downs Chin-Kuo Chang Richard G. Jackson Hitesh Shetty Matthew Broadbent Matthew Hotopf Robert Stewart

Clozapine can cause severe adverse effects yet it is associated with reduced mortality risk. We test the hypothesis this association is due to increased clinical monitoring and investigate risk of premature mortality from natural causes. We identified 14 754 individuals (879 deaths) with serious mental illness (SMI) including schizophrenia, schizoaffective and bipolar disorders aged ≥ 15 years ...

Journal: :Schizophrenia bulletin 1999
R Rosenheck D Evans L Herz J Cramer W Xu J Thomas W Henderson D Charney

This study compared the time course to clinical improvement with clozapine and with conventional antipsychotic medications. A double-blind trial compared clozapine and haloperidol in patients with schizophrenia who were refractory to conventional antipsychotic medication and were hospitalized for 30 to 364 days at 15 Veteran Affairs medical centers during the year before study entry. Patients i...

Journal: :The Australian and New Zealand journal of psychiatry 2011
Yu-Tao Xiang Chuan-Yue Wang Tian-Mei Si Edwin H M Lee Yan-Ling He Gabor S Ungvari Helen F K Chiu Naotaka Shinfuku Shu-Yu Yang Mian-Yoon Chong Ee-Heok Kua Senta Fujii Kang Sim Michael K H Yong Jitendra K Trivedi Eun-Kee Chung Pichet Udomratn Kok-Yoon Chee Norman Sartorius Lisa B Dixon Julie A Kreyenbuhl Chay-Hoon Tan

OBJECTIVE Optimizing treatment and outcomes for people with schizophrenia requires understanding of how evidence-based treatments are utilized. Clozapine is the most effective antipsychotic drug for treatment-refractory schizophrenia, but few studies have investigated trends and patterns of its use over time internationally. This study examined the prescription patterns of clozapine and its dem...

Journal: :Pharmacy Education 2023

Background: Clozapine, an atypical antipsychotic agent, is effective for relapse or refractory schizophrenia that has failed to respond other medications. Despite its effectiveness, clozapine a higher risk of metabolic syndrome than antipsychotics. Objective: This research aimed identify the correlation between and syndrome, such as obesity, cholesterol, blood glucose levels, in schizophrenic p...

2017
Saeed Ahmed Ali Mahmood Khan Hema Madhuri Mekala Hema Venigalla Rizwan Ahmed Amira Etman Michael Esang Mustafa Qureshi

Aim To assess the relative efficacies of clozapine plus Electroconvulsive Therapy (ECT) compared against non-clozapine typical and atypical antipsychotics plus ECT for the treatment of "Treatment Resistant Schizophrenia" (TRS). Primarily to assess if clozapine delivers a significant improvement over other antipsychotics when combined with ECT. Design Major electronic databases were searched b...

2017
Susanna Every-Palmer Roger G. Lentle Gordon Reynolds Corrin Hulls Paul Chambers Helen Dunn Pete M. Ellis

Background: Clozapine, an antipsychotic used in treatment-resistant schizophrenia, has adverse gastrointestinal effects with significant associated morbidity and mortality. However, its effects on defined patterns of colonic contractile activity have not been assessed. Method: We used novel radial and longitudinal spatiotemporal mapping techniques, combined with and monitoring of ambient lumen ...

Journal: :Schizophrenia bulletin 2009
Corrado Barbui Alessandra Signoretti Serena Mulè Marianna Boso Andrea Cipriani

In patients with schizophrenia who do not have an optimal response to clozapine, it remains unclear if there is an evidence base to support a second antipsychotic in combination with clozapine. The present systematic review was therefore carried out to determine the efficacy of various clozapine combination strategies with antipsychotics. Relevant studies were located by searching the Cochrane ...

2006
P. Tyrer

blood dyscrasia Dunk et al (2006) investigated 53 patients who were rechallenged with clozapine following leucopenia or neutropenia during previous therapy and found that 33 did not experience a second episode of blood dyscrasia and were able to continue drug treatment. This result is of considerable clinical relevance because it suggests that some patients with leucopenia or neutropenia may un...

2005

AIMS AND METHOD Clozapine is an effective drug in treatment-resistant schizophrenia, but it seems to be prescribed for few patients under the age of 18 years. This study reports a survey of consultant psychiatrists working in adolescent units in the UK, looking at their use of clozapine and experience with it. RESULTS Out of 83 clinicians, 59 responded (71%). More than 40% of respondents do not...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید